Beyond Biotech - the podcast from Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
Podcasting since 2022 • 165 episodes
Beyond Biotech - the podcast from Labiotech
Latest Episodes
BIOSPAIN 2025: Why 1000 companies from more than 40 countries will gather in Barcelona this year
Partnering conferences are where many deals in the biotech industry get made. With investors and top pharma companies on hand to meet with founders, learn about new science, and put money on the table for promising biotech, it’s little wonder t...
•
Episode 165
•
44:54
AION Labs is building innovative biotechs with top pharma partners in Israel
How can you guarantee that top pharma will be interested in investing in your biotech startup? How can you be sure that the target you are focused on will be attractive to industry partners? And can AI help drive this interest and deliver these...
•
Episode 164
•
42:09
Navigating the biotech development journey from first steps to global scale with Lonza
Lonza is one of the world’s largest contract development and manufacturing organizations (CDMOs), dedicated to serving the healthcare industry. They work alongside a broad range of customers – from emerging biotechs to top global pharmaceutical...
•
Episode 163
•
50:40
A Finnish biotech is making progress on Parkinson's disease with support from The Michael J. Fox Foundation
Parkinsons disease impacts some 10 million people worldwide and current approaches to treating the condition almost exclusively focus on addressing symptoms – there is, as of yet, no cure. One Finnish biotech, however, is not focused on allevia...
•
Episode 162
•
38:02
How RNAi is expanding from a therapy of choice for rare disease into treating common conditions
RNAi has changed the way that rare diseases are treated - is it about to do the same for more common conditions?Alnylam was the very first company to translate RNAi from Nobel Prize winning science into a commercially scalable pla...
•
Episode 161
•
48:01